The FDA is holding a meeting June 24, 2009 to solicit recommendations on ways the agency can make useful and understandable information about FDA activities and decisionmaking more readily available to the public. Among other things, the FDA is seeking comments on specific ways to announce FDA activities (e.g., enforcement actions, product approvals, and recalls), and what information should remain confidential in order to promote key internal and external policy goals.